one23

REGN: Oh, so nice. $403 first target.

Long
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
0
Observe the clean weekly gap up too.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.